Reputational Risk Is the Partner's Currency

The asymmetry

David Beckham had been pitched supplement brands by, in Danny Yeung's words, "so many people, big brands, very influential individuals," and turned them down for thirty years. Money was clearly never the obstacle. Yeung names the actual one: "For David, reputational risk was the key thing. If he puts his name on a product, no one's going to go after Danny. Everyone's going to go after David."¹ A founder's exposure to a failed product is a failed company, recoverable, and often one of several a serial founder will have. A famous partner's exposure is a permanent mark on the one asset they can never rebuild. Rationally, a partner in that position should demand a far higher standard of proof than an ordinary investor would, and should be far less movable by money alone.

What actually closed the deal

Yeung went to a summer 2023 dinner with Beckham, arranged through a mutual friend in Asian media, with no agenda and no expectation of pitching him at all. What resonated was a background combination rather than a pitch: an operator's history in consumer e-commerce, eleven years inside the life-sciences and diagnostics company Prenetics, and a Nasdaq-listed parent company audited by a major accounting firm since 2016 or 2017, an accountable, inspectable counterparty rather than a white-label operator. Each of those credentials reduces risk rather than promising growth, which functioned as Danny Yeung underwriting Beckham's reputational exposure with his own operating history and a public company's disclosure regime.

Yeung then added the second half himself, unprompted: "If we do this together, the brand also has to live beyond him."¹ That is counterintuitive as a pitch, since it explicitly reduces the celebrity's centrality to the business, and it is exactly why it worked: it signals a founder who is not trying to strip-mine a famous name for a fast exit. His stated reasoning was that initial interest fades if the product itself does not work, so a brand built to eventually stand on its own is a brand that, over time, releases its partner from the risk rather than compounding it, over a stated horizon of five to twenty years.

The structural expression of the idea

Every IM8 partnership is built to make a partner's risk manageable and their upside real. Deals run a minimum of three years, since short terms read as transactional and transactional deals are the ones that damage reputations. Partners hold a significant equity component, which Yeung says makes deals more selective precisely because equity is not transactional and forces a partner to do their own diligence, which is exactly what a founder wants from someone lending their name. Partners also use the product personally before any deal is discussed; Aryna Sabalenka reportedly used it for three months, after her nutrition coach trialed it for a month, before her own team initiated contact, meaning the partner had already validated the product they were about to risk their name on. Operating involvement stays deep, with weekly calls with David Beckham's team and Beckham holding final say on the taste profile of new products, since control is itself a form of risk mitigation. And negotiation stays founder-led rather than delegated: Yeung says he does not hand this off to other people, because it is delicate work when dealing with people at this level of exposure.¹

Why it matters

It inverts how most brands approach celebrity partnerships. The default is to model a partner's upside, reach, fee, conversion lift, and to compete on the size of the check. Yeung instead models the partner's downside and competes on how much of it he can absorb, an uncontested position against a field of bidders all pulling the same lever, and it is how a company with a market capitalization of roughly 50 million dollars beat thirty years of larger suitors to the deal.¹ It also explains why supplements specifically are hard to close famous partners into at all: the category is unregulated, so anyone can find a manufacturer and be selling within two weeks, which raises a partner's private risk and raises the value of a counterparty who volunteers scrutiny nobody requires them to accept.

The same logic at institutional scale

Bank of America CEO Brian Moynihan applies the identical logic one level up, with the bank's core checking franchise standing in for an individual partner's name: "We don't do subprime lending, and it's not because other people can't do it. It's just it's inconsistent with us being able to maintain the customer relationships at the level we have to maintain them."² The transferable point is that the same activity carries different expected value depending on what else an actor owns. A narrow lender risks only its loan book; a universal bank risks the deposit franchise that funds everything else it does.

Tensions

The account is told entirely from the founder's side, with Beckham's actual reasoning reported secondhand by his counterparty on a promotional podcast, which makes the thirty-years-of-rejections framing flattering to Yeung and unverifiable independently. Equity may also be doing more work than the narrative admits, since a co-founder stake in a Nasdaq-listed parent at a market capitalization that grew from roughly 50 million to several hundred million dollars is a large financial outcome in its own right, and risk absorption and well-timed equity are hard to fully disentangle. The claim that the brand has to live beyond Beckham is untested, given that IM8's highest-value product bundle is explicitly named after him. And the sample is survivorship-biased by nature: only the partnerships that closed are visible, while any partners who declined despite the same pitch, or deals structured this way that later failed, are not part of the record.